Chikatsu N - Search Results

1

Expression of p21(Cip1/Waf1/Sdi1) and p27(Kip1) cyclin-dependent kinase inhibitors during human hematopoiesis.

Taniguchi T, Endo H, Chikatsu N, Uchimaru K, Asano S, Fujita T, Nakahata T, Motokura T. Taniguchi T, et al. Among authors: chikatsu n. Blood. 1999 Jun 15;93(12):4167-78. Blood. 1999. PMID: 10361114 Free article.

2

Expression of p16INK4A and p14ARF in hematological malignancies.

Taniguchi T, Chikatsu N, Takahashi S, Fujita A, Uchimaru K, Asano S, Fujita T, Motokura T. Taniguchi T, et al. Among authors: chikatsu n. Leukemia. 1999 Nov;13(11):1760-9. doi: 10.1038/sj.leu.2401557. Leukemia. 1999. PMID: 10557050

3

p53 mutations and tetraploids under r- and K-selection.

Chikatsu N, Nakamura Y, Sato H, Fujita T, Asano S, Motokura T. Chikatsu N, et al. Oncogene. 2002 May 2;21(19):3043-9. doi: 10.1038/sj.onc.1205413. Oncogene. 2002. PMID: 12082535

4

Cloning and characterization of two promoters for the human calcium-sensing receptor (CaSR) and changes of CaSR expression in parathyroid adenomas.

Chikatsu N, Fukumoto S, Takeuchi Y, Suzawa M, Obara T, Matsumoto T, Fujita T. Chikatsu N, et al. J Biol Chem. 2000 Mar 17;275(11):7553-7. doi: 10.1074/jbc.275.11.7553. J Biol Chem. 2000. PMID: 10713061 Free article.

5

Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro.

Chikatsu N, Takeuchi Y, Tamura Y, Fukumoto S, Yano K, Tsuda E, Ogata E, Fujita T. Chikatsu N, et al. Biochem Biophys Res Commun. 2000 Jan 19;267(2):632-7. doi: 10.1006/bbrc.1999.2008. Biochem Biophys Res Commun. 2000. PMID: 10631114

6

Inactivating mutations of calcium-sensing receptor results in parathyroid lipohyperplasia.

Fukumoto S, Chikatsu N, Okazaki R, Takeuchi Y, Tamura Y, Murakami T, Obara T, Fujita T. Fukumoto S, et al. Among authors: chikatsu n. Diagn Mol Pathol. 2001 Dec;10(4):242-7. doi: 10.1097/00019606-200112000-00006. Diagn Mol Pathol. 2001. PMID: 11763315

7

An adult patient with severe hypercalcaemia and hypocalciuria due to a novel homozygous inactivating mutation of calcium-sensing receptor.

Chikatsu N, Fukumoto S, Suzawa M, Tanaka Y, Takeuchi Y, Takeda S, Tamura Y, Matsumoto T, Fujita T. Chikatsu N, et al. Clin Endocrinol (Oxf). 1999 Apr;50(4):537-43. doi: 10.1046/j.1365-2265.1999.00729.x. Clin Endocrinol (Oxf). 1999. PMID: 10468915

8

A novel activating mutation in calcium-sensing receptor gene associated with a family of autosomal dominant hypocalcemia.

Okazaki R, Chikatsu N, Nakatsu M, Takeuchi Y, Ajima M, Miki J, Fujita T, Arai M, Totsuka Y, Tanaka K, Fukumoto S. Okazaki R, et al. Among authors: chikatsu n. J Clin Endocrinol Metab. 1999 Jan;84(1):363-6. doi: 10.1210/jcem.84.1.5385. J Clin Endocrinol Metab. 1999. PMID: 9920108

9

ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC).

Chikatsu N, Kojima H, Suzukawa K, Shinagawa A, Nagasawa T, Ozawa H, Yamashita Y, Mori N. Chikatsu N, et al. Mod Pathol. 2003 Aug;16(8):828-32. doi: 10.1097/01.MP.0000081729.40230.1F. Mod Pathol. 2003. PMID: 12920229

10

Adherence to the standard dose of imatinib, rather than dose adjustment based on its plasma concentration, is critical to achieve a deep molecular response in patients with chronic myeloid leukemia.

Yoshida C, Komeno T, Hori M, Kimura T, Fujii M, Okoshi Y, Suzukawa K, Chiba S, Hasegawa Y, Mukai HY, Ito T, Shimizu S, Kamoshita M, Kudo D, Shinagawa A, Chikatsu N, Monma Y, Watanabe N, Kojima H. Yoshida C, et al. Among authors: chikatsu n. Int J Hematol. 2011 May;93(5):618-623. doi: 10.1007/s12185-011-0838-3. Epub 2011 Apr 22. Int J Hematol. 2011. PMID: 21523339

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters